Year |
Citation |
Score |
Low-probability matches (unlikely to be authored by this person) |
2003 |
Watamaniuk SN, Flinn J, Stohr RE. Segregation from direction differences in dynamic random-dot stimuli. Vision Research. 43: 171-80. PMID 12536139 DOI: 10.1016/S0042-6989(02)00434-0 |
0.283 |
|
2019 |
Niethammer M, Widmann M, Rendler T, Morioka N, Chen YC, Stöhr R, Hassan JU, Onoda S, Ohshima T, Lee SY, Mukherjee A, Isoya J, Son NT, Wrachtrup J. Coherent electrical readout of defect spins in silicon carbide by photo-ionization at ambient conditions. Nature Communications. 10: 5569. PMID 31804489 DOI: 10.1038/S41467-019-13545-Z |
0.161 |
|
2020 |
Morioka N, Babin C, Nagy R, Gediz I, Hesselmeier E, Liu D, Joliffe M, Niethammer M, Dasari D, Vorobyov V, Kolesov R, Stöhr R, Ul-Hassan J, Son NT, Ohshima T, et al. Spin-controlled generation of indistinguishable and distinguishable photons from silicon vacancy centres in silicon carbide. Nature Communications. 11: 2516. PMID 32433556 DOI: 10.1038/s41467-020-16330-5 |
0.156 |
|
2022 |
Vollbrecht C, Hoffmann I, Lehmann A, Merkelbach-Bruse S, Fassunke J, Wagener-Ryczek S, Ball M, Dimitrova L, Hartmann A, Stöhr R, Erber R, Weichert W, Pfarr N, Bohlmann L, Jung A, et al. Proficiency testing of PIK3CA mutations in HR+/HER2-breast cancer on liquid biopsy and tissue. Virchows Archiv : An International Journal of Pathology. PMID 36367572 DOI: 10.1007/s00428-022-03445-x |
0.137 |
|
2021 |
Bian K, Zheng W, Zeng X, Chen X, Stöhr R, Denisenko A, Yang S, Wrachtrup J, Jiang Y. Nanoscale electric-field imaging based on a quantum sensor and its charge-state control under ambient condition. Nature Communications. 12: 2457. PMID 33911073 DOI: 10.1038/s41467-021-22709-9 |
0.137 |
|
2013 |
Kolesov R, Xia K, Reuter R, Jamali M, Stöhr R, Inal T, Siyushev P, Wrachtrup J. Mapping spin coherence of a single rare-earth ion in a crystal onto a single photon polarization state. Physical Review Letters. 111: 120502. PMID 24093236 DOI: 10.1103/PhysRevLett.111.120502 |
0.135 |
|
2016 |
Hedegaard J, Lamy P, Nordentoft I, Algaba F, Høyer S, Ulhøi BP, Vang S, Reinert T, Hermann GG, Mogensen K, Thomsen MB, Nielsen MM, Marquez M, Segersten U, Aine M, et al. Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma. Cancer Cell. PMID 27321955 DOI: 10.1016/J.Ccell.2016.05.004 |
0.132 |
|
2021 |
Babin C, Stöhr R, Morioka N, Linkewitz T, Steidl T, Wörnle R, Liu D, Hesselmeier E, Vorobyov V, Denisenko A, Hentschel M, Gobert C, Berwian P, Astakhov GV, Knolle W, et al. Fabrication and nanophotonic waveguide integration of silicon carbide colour centres with preserved spin-optical coherence. Nature Materials. PMID 34795400 DOI: 10.1038/s41563-021-01148-3 |
0.132 |
|
2008 |
Nawroth R, Stöhr R, Hartmann A, Gschwend JE, Retz M. [EMMPRIN (CD147). A new key protein during tumor progression in bladder cancer]. Der Urologe. Ausg. A. 47: 1152-6. PMID 18688595 DOI: 10.1007/s00120-008-1828-9 |
0.128 |
|
2020 |
Heupel J, Pallmann M, Körber J, Merz R, Kopnarski M, Stöhr R, Reithmaier JP, Hunger D, Popov C. Fabrication and Characterization of Single-Crystal Diamond Membranes for Quantum Photonics with Tunable Microcavities. Micromachines. 11. PMID 33291795 DOI: 10.3390/mi11121080 |
0.125 |
|
2023 |
Neethirajan JN, Hache T, Paone D, Pinto D, Denisenko A, Stöhr R, Udvarhelyi P, Pershin A, Gali A, Wrachtrup J, Kern K, Singha A. Controlled Surface Modification to Revive Shallow NV Centers. Nano Letters. PMID 36927005 DOI: 10.1021/acs.nanolett.2c04733 |
0.125 |
|
2021 |
Lieb V, Abdulrahman A, Weigelt K, Hauch S, Gombert M, Guzman J, Bellut L, Goebell PJ, Stöhr R, Hartmann A, Wullich B, Taubert H, Wach S. Cell-Free DNA Variant Sequencing Using Plasma and AR-V7 Testing of Circulating Tumor Cells in Prostate Cancer Patients. Cells. 10. PMID 34831445 DOI: 10.3390/cells10113223 |
0.121 |
|
2024 |
Kumar J, Yudilevich D, Smooha A, Zohar I, Pariari AK, Stöhr R, Denisenko A, Hücker M, Finkler A. Room Temperature Relaxometry of Single Nitrogen Vacancy Centers in Proximity to α-RuCl Nanoflakes. Nano Letters. PMID 38588382 DOI: 10.1021/acs.nanolett.3c05090 |
0.12 |
|
2023 |
Tögel L, Schubart C, Lettmaier S, Neufert C, Hoyer J, Wolff K, Moskalev EA, Stöhr R, Agaimy A, Reis A, Wullich B, Mackensen A, Pavel M, Beckmann MW, Hartmann A, et al. Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer Center. Cancers. 15. PMID 38136436 DOI: 10.3390/cancers15245892 |
0.12 |
|
2020 |
Maurer A, Ortiz-Bruechle N, Guricova K, Rose M, Morsch R, Garczyk S, Stöhr R, Bertz S, Golz R, Reis H, Bremmer F, Zimpfer A, Siegert S, Kristiansen G, Schwamborn K, et al. Comparative genomic profiling of glandular bladder tumours. Virchows Archiv : An International Journal of Pathology. PMID 32198650 DOI: 10.1007/s00428-020-02787-8 |
0.115 |
|
2015 |
Poyet C, Hermanns T, Zhong Q, Drescher E, Eberli D, Burger M, Hofstaedter F, Hartmann A, Stöhr R, Zwarthoff EC, Sulser T, Wild PJ. Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancer. Oncology Letters. 10: 2753-2760. PMID 26722237 DOI: 10.3892/ol.2015.3691 |
0.113 |
|
2011 |
Kullmann F, Hartmann A, Stöhr R, Messmann H, Dollinger MM, Trojan J, Fuchs M, Hollerbach S, Harder J, Troppmann M, Kutscheidt A, Endlicher E. KRAS mutation in metastatic pancreatic ductal adenocarcinoma: results of a multicenter phase II study evaluating efficacy of cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line therapy. Oncology. 81: 3-8. PMID 21894049 DOI: 10.1159/000330194 |
0.112 |
|
2019 |
Oeckinghaus T, Momenzadeh SA, Scheiger P, Shalomayeva T, Finkler A, Dasari D, Stöhr R, Wrachtrup J. Spin-Phonon Interfaces in Coupled Nanomechanical Cantilevers. Nano Letters. PMID 31820999 DOI: 10.1021/Acs.Nanolett.9B04198 |
0.111 |
|
2011 |
Nawroth R, Hartmann A, Olbert PJ, Merseburger AS, Stöhr R, Knüchel R, Retz M, Füssel S. [Bladder cancer update: what was new at the 2010 annual congress of the German Association of Urology in Düsseldorf?]. Der Urologe. Ausg. A. 50: 221-6. PMID 21246347 DOI: 10.1007/s00120-010-2486-2 |
0.109 |
|
2018 |
Stöhr R, Schuh A, Heine GH, Brandenburg V. FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator? Frontiers in Endocrinology. 9: 351. PMID 30013515 DOI: 10.3389/fendo.2018.00351 |
0.106 |
|
2023 |
Bahlinger V, Eckstein M, Hartmann A, Stöhr R. Evaluation of FGFR Alteration Status in Urothelial Tumors. Methods in Molecular Biology (Clifton, N.J.). 2684: 283-291. PMID 37410241 DOI: 10.1007/978-1-0716-3291-8_17 |
0.106 |
|
2012 |
Kolesov R, Xia K, Reuter R, Stöhr R, Zappe A, Meijer J, Hemmer PR, Wrachtrup J. Optical detection of a single rare-earth ion in a crystal. Nature Communications. 3: 1029. PMID 22929786 DOI: 10.1038/ncomms2034 |
0.104 |
|
2012 |
Stöhr R, Marx N. Renin-angiotensin-aldosterone system antagonists and the prevention of type 2 diabetes mellitus Current Pharmaceutical Design. 18: 958-962. PMID 22283775 DOI: 10.2174/138161212799436557 |
0.103 |
|
2013 |
Keck B, Merseburger AS, Stöhr R, Füssel S, Hoffmann MJ, Schmid S, Olbert P, Hartmann A, Nawroth R. [Bladder cancer in focus: update 2012 of the German Bladder Cancer Association]. Der Urologe. Ausg. A. 52: 373-7. PMID 23358832 DOI: 10.1007/s00120-012-3111-3 |
0.102 |
|
2011 |
Nawroth R, Hartmann A, Wild P, Lehmann J, Stöhr R, Gschwend JE, Retz M. [EMMPRIN (CD147). A prognostic and potentially therapeutic marker in urothelial cancer]. Der Pathologe. 251-4. PMID 20661575 DOI: 10.1007/s00292-010-1328-8 |
0.102 |
|
2011 |
Pilchowski R, Stöhr R, von Eggeling F, Hartmann A, Wunderlich H, Junker K. Specific protein patterns characterize metastatic potential of advanced bladder cancer. The Journal of Urology. 186: 713-20. PMID 21683396 DOI: 10.1016/j.juro.2011.03.124 |
0.101 |
|
2018 |
Geelvink M, Babmorad A, Maurer A, Stöhr R, Grimm T, Bach C, Knuechel R, Rose M, Gaisa NT. Diagnostic and Prognostic Implications of FGFR3/Ki67 Papillary Bladder Cancers. International Journal of Molecular Sciences. 19. PMID 30154342 DOI: 10.3390/ijms19092548 |
0.101 |
|
2020 |
Weyerer V, Eckstein M, Compérat E, Juette H, Gaisa NT, Allory Y, Stöhr R, Wullich B, Rouprêt M, Hartmann A, Bertz S. Pure Large Nested Variant of Urothelial Carcinoma (LNUC) Is the Prototype of an Mutated Aggressive Urothelial Carcinoma with Luminal-Papillary Phenotype. Cancers. 12. PMID 32213857 DOI: 10.3390/cancers12030763 |
0.1 |
|
2016 |
Wirtz RM, Fritz V, Stöhr R, Hartmann A. [Molecular classification of bladder cancer. Possible similarities to breast cancer]. Der Pathologe. 37: 52-60. PMID 26780243 DOI: 10.1007/s00292-015-0134-8 |
0.1 |
|
2021 |
Mertens LS, Claps F, Mayr R, Bostrom PJ, Shariat SF, Zwarthoff EC, Boormans JL, Abas C, van Leenders GJLH, Götz S, Hippe K, Bertz S, Neuzillet Y, Sanders J, Broeks A, et al. Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients. Urologic Oncology. 40: 110.e1-110.e9. PMID 34906411 DOI: 10.1016/j.urolonc.2021.10.010 |
0.099 |
|
2022 |
Kloker LD, Calukovic B, Benzler K, Golf A, Böhm S, Günther S, Horger M, Haas S, Berchtold S, Beil J, Carter ME, Ganzenmueller T, Singer S, Agaimy A, Stöhr R, et al. Case report: Immunovirotherapy as a novel add-on treatment in a patient with thoracic NUT carcinoma. Frontiers in Oncology. 12: 995744. PMID 36387105 DOI: 10.3389/fonc.2022.995744 |
0.099 |
|
2016 |
Rau TT, Atreya R, Aust D, Baretton G, Eck M, Erlenbach-Wünsch K, Hartmann A, Lugli A, Stöhr R, Vieth M, Wirsing AM, Zlobec I, Katzenberger T. Inflammatory response in serrated precursor lesions of the colon classified according to WHO entities, clinical parameters and phenotype-genotype correlation. The Journal of Pathology. Clinical Research. 2: 113-24. PMID 27499921 DOI: 10.1002/cjp2.41 |
0.098 |
|
2021 |
Schmitz-Dräger BJ, Skutetzki A, Rieker RJ, Schwab SA, Stöhr R, Bismarck E, Savov O, Ebert T, Benderska-Söder N, Hartmann A. Eosinophilic cystitis mimicking bladder cancer-considerations on the management based upon a case report and a review of the literature. Virchows Archiv : An International Journal of Pathology. PMID 33576854 DOI: 10.1007/s00428-021-03049-x |
0.097 |
|
2016 |
Laible M, Schlombs K, Kaiser K, Veltrup E, Herlein S, Lakis S, Stöhr R, Eidt S, Hartmann A, Wirtz RM, Sahin U. Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens. Bmc Cancer. 16: 398. PMID 27389414 DOI: 10.1186/s12885-016-2476-x |
0.095 |
|
2022 |
Erber R, Angeloni M, Stöhr R, Lux MP, Ulbrich-Gebauer D, Pelz E, Bankfalvi A, Schmid KW, Walter RFH, Vetter M, Thomssen C, Mayr D, Klauschen F, Sinn P, Sotlar K, et al. Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World Setting. International Journal of Molecular Sciences. 23. PMID 35955851 DOI: 10.3390/ijms23158716 |
0.094 |
|
2004 |
Knüchel R, Hartmann A, Stöhr R, Baumgartner R, Zaak D, Krieg RC. [Precancerous conditions in the urothelium. Early detection and molecular understanding through endoscopic fluorescence diagnosis]. Der Pathologe. 24: 473-9. PMID 14605854 DOI: 10.1007/s00292-003-0651-8 |
0.094 |
|
2018 |
Eckstein M, Jung R, Weigelt K, Sikic D, Stöhr R, Geppert C, Agaimy A, Lieb V, Hartmann A, Wullich B, Wach S, Taubert H. Piwi-like 1 and -2 protein expression levels are prognostic factors for muscle invasive urothelial bladder cancer patients. Scientific Reports. 8: 17693. PMID 30523270 DOI: 10.1038/s41598-018-35637-4 |
0.094 |
|
2010 |
Neulinger SC, Stöhr R, Thiel V, Schmaljohann R, Imhoff JF. New phylogenetic lineages of the Spirochaetes phylum associated with Clathrina species (Porifera). Journal of Microbiology (Seoul, Korea). 48: 411-8. PMID 20799080 DOI: 10.1007/s12275-010-0017-x |
0.093 |
|
2008 |
Junker K, Pilchowski R, Stöhr R, von Eggeling F, Schubert J, Hartmann A. [Definition of specific protein patterns for advanced (metastatic) urinary bladder tumors for individual prognosis determination and treatment choice]. Der Urologe. Ausg. A. 46: 1288. PMID 17593341 DOI: 10.1007/s00120-007-1398-2 |
0.091 |
|
2020 |
Eckstein M, Epple E, Jung R, Weigelt K, Lieb V, Sikic D, Stöhr R, Geppert C, Weyerer V, Bertz S, Kehlen A, Hartmann A, Wullich B, Taubert H, Wach S. CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node Stage. Cancers. 12. PMID 32429318 DOI: 10.3390/cancers12051253 |
0.091 |
|
2010 |
Hoffmann AC, Wild P, Leicht C, Bertz S, Danenberg KD, Danenberg PV, Stöhr R, Stöckle M, Lehmann J, Schuler M, Hartmann A. MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy. Neoplasia (New York, N.Y.). 12: 628-36. PMID 20689757 DOI: 10.1593/Neo.10402 |
0.091 |
|
2024 |
Schlieben LD, Carta MG, Moskalev EA, Stöhr R, Metzler M, Besendörfer M, Meidenbauer N, Semrau S, Janka R, Grützmann R, Wiemann S, Hartmann A, Agaimy A, Haller F, Ferrazzi F. Machine Learning-Supported Diagnosis of Small Blue Round Cell Sarcomas Using Targeted RNA Sequencing. The Journal of Molecular Diagnostics : Jmd. PMID 38395409 DOI: 10.1016/j.jmoldx.2024.02.002 |
0.091 |
|
2020 |
Stöhr R, Brandenburg VM, Heine GH, Maeder MT, Leibundgut G, Schuh A, Jeker U, Pfisterer M, Sanders-van Wijk S, Brunner-la Rocca HP. Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME-CHF trial. European Journal of Heart Failure. 22: 701-709. PMID 32020782 DOI: 10.1002/ejhf.1749 |
0.09 |
|
2015 |
Aslam N, Pfender M, Stöhr R, Neumann P, Scheffler M, Sumiya H, Abe H, Onoda S, Ohshima T, Isoya J, Wrachtrup J. Single spin optically detected magnetic resonance with 60-90 GHz (E-band) microwave resonators. The Review of Scientific Instruments. 86: 064704. PMID 26133855 DOI: 10.1063/1.4922664 |
0.09 |
|
2015 |
Kraus C, Rau TT, Lux P, Erlenbach-Wünsch K, Löhr S, Krumbiegel M, Thiel CT, Stöhr R, Agaimy A, Croner RS, Stürzl M, Hohenberger W, Hartmann A, Reis A. Comprehensive screening for mutations associated with colorectal cancer in unselected cases reveals penetrant and nonpenetrant mutations. International Journal of Cancer. Journal International Du Cancer. 136: E559-68. PMID 25142776 DOI: 10.1002/Ijc.29149 |
0.089 |
|
2017 |
Sikic D, Breyer J, Hartmann A, Burger M, Erben P, Denzinger S, Eckstein M, Stöhr R, Wach S, Wullich B, Keck B, Wirtz RM, Otto W. High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer. Translational Oncology. 10: 340-345. PMID 28342317 DOI: 10.1016/j.tranon.2017.01.013 |
0.087 |
|
2023 |
Claps F, van de Kamp MW, Mayr R, Bostrom PJ, Shariat SF, Hippe K, Bertz S, Neuzillet Y, Sanders J, Otto W, van der Heijden MS, Jewett MAS, Stöhr R, Zlotta AR, Trombetta C, et al. Prognostic impact of variant histologies in urothelial bladder cancer treated by radical cystectomy. Bju International. PMID 36748180 DOI: 10.1111/bju.15984 |
0.087 |
|
2008 |
Stöhr R, Catto JW, Azzouzi A, Rehmann I, Feeley K, Meuth M, Hamdy F, Burger M, Hartmann A. [Promoter methylation and microsatellite mutation reveals the clonal relationship of multiple urothelial carcinomas with mutator phenotype]. Verhandlungen Der Deutschen Gesellschaft Fur Pathologie. 89: 225-33. PMID 18035696 |
0.087 |
|
2018 |
Worst TS, Weis CA, Stöhr R, Bertz S, Eckstein M, Otto W, Breyer J, Hartmann A, Bolenz C, Wirtz RM, Erben P. CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making. Scientific Reports. 8: 14383. PMID 30258198 DOI: 10.1038/s41598-018-32569-x |
0.087 |
|
2014 |
Bertz S, Otto W, Denzinger S, Wieland WF, Burger M, Stöhr R, Link S, Hofstädter F, Hartmann A. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer. European Urology. 65: 218-26. PMID 22633802 DOI: 10.1016/j.eururo.2012.05.033 |
0.086 |
|
2020 |
Kubon J, Sikic D, Eckstein M, Weyerer V, Stöhr R, Neumann A, Keck B, Wullich B, Hartmann A, Wirtz RM, Taubert H, Wach S. Analysis of CXCL9, PD1 and PD-L1 mRNA in Stage T1 Non-Muscle Invasive Bladder Cancer and Their Association with Prognosis. Cancers. 12. PMID 33003392 DOI: 10.3390/cancers12102794 |
0.086 |
|
2018 |
Shagieva F, Zaiser S, Neumann P, Dasari DBR, Stöhr R, Denisenko A, Reuter R, Meriles CA, Wrachtrup J. Microwave-Assisted Cross-Polarization of Nuclear Spin Ensembles from Optically Pumped Nitrogen-Vacancy Centers in Diamond. Nano Letters. 18: 3731-3737. PMID 29719156 DOI: 10.1021/Acs.Nanolett.8B00925 |
0.085 |
|
2019 |
Wach S, Brandl M, Borchardt H, Weigelt K, Lukat S, Nolte E, Al-Janabi O, Hart M, Grässer F, Giedl J, Jung R, Stöhr R, Hartmann A, Lieb V, Höbel S, et al. Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo. Molecular Therapy. Nucleic Acids. 16: 272-283. PMID 30933831 DOI: 10.1016/j.omtn.2019.02.020 |
0.085 |
|
2020 |
König P, Eckstein M, Jung R, Abdulrahman A, Guzman J, Weigelt K, Serrero G, Hayashi J, Geppert C, Stöhr R, Hartmann A, Wullich B, Wach S, Taubert H, Lieb V. Expression of AR-V7 (Androgen Receptor Variant 7) Protein in Granular Cytoplasmic Structures Is an Independent Prognostic Factor in Prostate Cancer Patients. Cancers. 12. PMID 32947898 DOI: 10.3390/cancers12092639 |
0.085 |
|
2021 |
Eckstein M, Lieb V, Jung R, Sikic D, Weigelt K, Stöhr R, Geppert C, Weyerer V, Bertz S, Serrero G, Yue B, Hartmann A, Wullich B, Taubert H, Wach S. Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer Patients. Cells. 10. PMID 34359965 DOI: 10.3390/cells10071796 |
0.083 |
|
2021 |
Schubart C, Stöhr R, Tögel L, Fuchs F, Sirbu H, Seitz G, Seggewiss-Bernhardt R, Leistner R, Sterlacci W, Vieth M, Seidl C, Mugler M, Kapp M, Hohenforst-Schmidt W, Hartmann A, et al. Amplification in Non-Small Cell Lung Cancer (NSCLC)-A Consecutive Evaluation Using Next-Generation Sequencing (NGS) in a Real-World Setting. Cancers. 13. PMID 34638507 DOI: 10.3390/cancers13195023 |
0.083 |
|
2021 |
Song T, Sun QC, Anderson E, Wang C, Qian J, Taniguchi T, Watanabe K, McGuire MA, Stöhr R, Xiao D, Cao T, Wrachtrup J, Xu X. Direct visualization of magnetic domains and moiré magnetism in twisted 2D magnets. Science (New York, N.Y.). 374: 1140-1144. PMID 34822270 DOI: 10.1126/science.abj7478 |
0.083 |
|
2005 |
Klopocki E, Kristiansen G, Wild PJ, Klaman I, Castanos-Velez E, Singer G, Stöhr R, Simon R, Sauter G, Leibiger H, Essers L, Weber B, Hermann K, Rosenthal A, Hartmann A, et al. Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors. International Journal of Oncology. 25: 641-9. PMID 15289865 |
0.082 |
|
2005 |
Singer G, Stöhr R, Cope L, Dehari R, Hartmann A, Cao DF, Wang TL, Kurman RJ, Shih IeM. Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation. The American Journal of Surgical Pathology. 29: 218-24. PMID 15644779 DOI: 10.1097/01.pas.0000146025.91953.8d |
0.082 |
|
2020 |
Bertz S, Stöhr R, Gaisa NT, Wullich B, Hartmann A, Agaimy A. TERT promoter mutation analysis as a surrogate to morphology and immunohistochemistry in problematic spindle cell lesions of the urinary bladder. Histopathology. 77: 949-962. PMID 32645760 DOI: 10.1111/his.14206 |
0.081 |
|
2019 |
Abdulrahman A, Eckstein M, Jung R, Guzman J, Weigelt K, Serrero G, Yue B, Geppert C, Stöhr R, Hartmann A, Wullich B, Wach S, Taubert H, Lieb V. Expression of GP88 (Progranulin) Protein Is an Independent Prognostic Factor in Prostate Cancer Patients. Cancers. 11. PMID 31888257 DOI: 10.3390/cancers11122029 |
0.08 |
|
2019 |
Ortiz-Brüchle N, Muders M, Toma M, Esposito I, Hartmann A, Stöhr R, Reis H, Wild P, Köllermann J, Bremmer F, Leichsenring J, Stenzinger A, Merkelbach-Bruse S, Kirfel S, Perner S, et al. [Status of the availability and use of next generation sequencing (NGS) in bladder cancer-a questionnaire within the uropathology working group]. Der Urologe. Ausg. A. PMID 31541269 DOI: 10.1007/s00120-019-01046-2 |
0.08 |
|
2022 |
Stöhr R, Dirrichs T, Kneizeh K, Reinartz S, Frank D, Brachmann J, Schroeder J, Schurgers L, Göttsch C, Keszei A, Floege J, Marx N, Brandenburg V, Schuh A. Influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification in patients with atrial fibrillation and/or pulmonary embolism. Clinical Cardiology. PMID 35332571 DOI: 10.1002/clc.23819 |
0.079 |
|
2010 |
Szczyrba J, Löprich E, Wach S, Jung V, Unteregger G, Barth S, Grobholz R, Wieland W, Stöhr R, Hartmann A, Wullich B, Grässer F. The microRNA profile of prostate carcinoma obtained by deep sequencing. Molecular Cancer Research : McR. 8: 529-38. PMID 20353999 DOI: 10.1158/1541-7786.MCR-09-0443 |
0.079 |
|
2022 |
Schrenk KG, Weschenfelder W, Spiegel C, Agaimy A, Stöhr R, Hartmann A, Gaßler N, Drescher R, Freesmeyer M, Malouhi A, Bürckenmeyer F, Aschenbach R, Teichgräber U, Kögler C, Vogt M, et al. Exceptional response to neoadjuvant targeted therapy with the selective RET inhibitor selpercatinib in RET-fusion-associated sarcoma. Journal of Cancer Research and Clinical Oncology. PMID 36469155 DOI: 10.1007/s00432-022-04496-y |
0.078 |
|
2022 |
Fichte A, Neumann A, Weigelt K, Guzman J, Jansen T, Keinert J, Serrero G, Yue B, Stöhr R, Greither T, Hartmann A, Wullich B, Taubert H, Wach S, Lieb V. Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer Patients. Life (Basel, Switzerland). 12. PMID 35629399 DOI: 10.3390/life12050732 |
0.077 |
|
2021 |
Haller F, Schlieben LD, Ferrazzi F, Michal M, Stöhr R, Moskalev EA, Bieg M, Bovée JVMG, Ströbel P, Ishaque N, Grützmann R, Meidenbauer N, Eils R, Wiemann S, Hartmann A, et al. Lipomatous Solitary Fibrous Tumors Harbor Rare NAB2-STAT6 Fusion Variants and Show Up-Regulation of the Gene PPARG, Encoding for a Regulator of Adipocyte Differentiation. The American Journal of Pathology. PMID 33887215 DOI: 10.1016/j.ajpath.2021.03.012 |
0.076 |
|
2021 |
Erber R, Hartmann A, Fasching PA, Ruebner M, Stöhr R, Beckmann MW, Zentgraf M, Popp V, Weidler J, Simon I, Becker S, Huebner H, Fischer J, Guerini Rocco E, Viale G, et al. Reproducibility of mRNA-Based Testing of , , , and Expression in Invasive Breast Cancer-A Europe-Wide External Quality Assessment. Cancers. 13. PMID 34572945 DOI: 10.3390/cancers13184718 |
0.075 |
|
2013 |
Szczyrba J, Nolte E, Hart M, Döll C, Wach S, Taubert H, Keck B, Kremmer E, Stöhr R, Hartmann A, Wieland W, Wullich B, Grässer FA. Identification of ZNF217, hnRNP-K, VEGF-A and IPO7 as targets for microRNAs that are downregulated in prostate carcinoma. International Journal of Cancer. 132: 775-84. PMID 22815235 DOI: 10.1002/ijc.27731 |
0.075 |
|
2021 |
Taubert H, Eckstein M, Epple E, Jung R, Weigelt K, Lieb V, Sikic D, Stöhr R, Geppert C, Weyerer V, Bertz S, Kehlen A, Hartmann A, Wullich B, Wach S. Immune Cell-Associated Protein Expression Helps to Predict Survival in Muscle-Invasive Urothelial Bladder Cancer Patients after Radical Cystectomy and Optional Adjuvant Chemotherapy. Cells. 10. PMID 33467469 DOI: 10.3390/cells10010159 |
0.074 |
|
2013 |
Moskalev EA, Stöhr R, Rieker R, Hebele S, Fuchs F, Sirbu H, Mastitsky SE, Boltze C, König H, Agaimy A, Hartmann A, Haller F. Increased detection rates of EGFR and KRAS mutations in NSCLC specimens with low tumour cell content by 454 deep sequencing. Virchows Archiv : An International Journal of Pathology. 462: 409-19. PMID 23468066 DOI: 10.1007/s00428-013-1376-6 |
0.073 |
|
2016 |
Mavilio M, Marchetti V, Fabrizi M, Stöhr R, Marino A, Casagrande V, Fiorentino L, Cardellini M, Kappel B, Monteleone I, Garret C, Mauriello A, Monteleone G, Farcomeni A, Burcelin R, et al. A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction. Cell Reports. 16: 731-43. PMID 27373162 DOI: 10.1016/j.celrep.2016.06.027 |
0.073 |
|
2017 |
Dyrskjøt L, Reinert T, Algaba F, Christensen E, Nieboer D, Hermann GG, Mogensen K, Beukers W, Marquez M, Segersten U, Høyer S, Ulhøi BP, Hartmann A, Stöhr R, Wach S, et al. Prognostic Impact of a 12-gene Progression Score in Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study. European Urology. PMID 28583312 DOI: 10.1016/J.Eururo.2017.05.040 |
0.072 |
|
2014 |
Oeckinghaus T, Stöhr R, Kolesov R, Tisler J, Reinhard F, Wrachtrup J. A compact, diode laser based excitation system for microscopy of NV centers. The Review of Scientific Instruments. 85: 073101. PMID 25085121 DOI: 10.1063/1.4885469 |
0.071 |
|
2022 |
Lieb V, Abdulrahman A, Weigelt K, Hauch S, Gombert M, Guzman J, Bellut L, Goebell PJ, Stöhr R, Hartmann A, Wullich B, Taubert H, Wach S. Cell-Free DNA Sequencing Reveals Gene Variants in DNA Damage Repair Genes Associated with Prognosis of Prostate Cancer Patients. Cells. 11. PMID 36429046 DOI: 10.3390/cells11223618 |
0.07 |
|
2020 |
Ory NC, Lehmann A, Javidpour J, Stöhr R, Walls GL, Clemmesen C. Factors influencing the spatial and temporal distribution of microplastics at the sea surface - A year-long monitoring case study from the urban Kiel Fjord, southwest Baltic Sea. The Science of the Total Environment. 736: 139493. PMID 32497878 DOI: 10.1016/j.scitotenv.2020.139493 |
0.07 |
|
2021 |
Sun QC, Song T, Anderson E, Brunner A, Förster J, Shalomayeva T, Taniguchi T, Watanabe K, Gräfe J, Stöhr R, Xu X, Wrachtrup J. Magnetic domains and domain wall pinning in atomically thin CrBr revealed by nanoscale imaging. Nature Communications. 12: 1989. PMID 33790290 DOI: 10.1038/s41467-021-22239-4 |
0.067 |
|
2012 |
Wach S, Nolte E, Szczyrba J, Stöhr R, Hartmann A, Ørntoft T, Dyrskjøt L, Eltze E, Wieland W, Keck B, Ekici AB, Grässer F, Wullich B. MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening. International Journal of Cancer. 130: 611-21. PMID 21400514 DOI: 10.1002/ijc.26064 |
0.066 |
|
2005 |
Imhoff JF, Stöhr R. Sponge-associated bacteria: general overview and special aspects of bacteria associated with Halichondria panicea. Progress in Molecular and Subcellular Biology. 37: 35-57. PMID 15825639 DOI: 10.1007/978-3-642-55519-0_2 |
0.066 |
|
2009 |
Retz M, Nawroth R, Olbert P, Hartmann A, Stöhr R, Merseburger AS, Schulz W. [Symposium of the German Bladder Cancer Association]. Der Urologe. Ausg. A. 48: 1517-22. PMID 19890622 DOI: 10.1007/s00120-009-2132-z |
0.065 |
|
2015 |
Wach S, Al-Janabi O, Weigelt K, Fischer K, Greither T, Marcou M, Theil G, Nolte E, Holzhausen HJ, Stöhr R, Huppert V, Hartmann A, Fornara P, Wullich B, Taubert H. The combined serum levels of miR-375 and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer. International Journal of Cancer. Journal International Du Cancer. 137: 1406-16. PMID 25754273 DOI: 10.1002/ijc.29505 |
0.064 |
|
2011 |
Szczyrba J, Nolte E, Wach S, Kremmer E, Stöhr R, Hartmann A, Wieland W, Wullich B, Grässer FA. Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma. Molecular Cancer Research : McR. 9: 791-800. PMID 21593139 DOI: 10.1158/1541-7786.MCR-10-0573 |
0.063 |
|
2017 |
Zink MD, Brüser C, Stüben BO, Napp A, Stöhr R, Leonhardt S, Marx N, Mischke K, Schulz JB, Schiefer J. Unobtrusive Nocturnal Heartbeat Monitoring by a Ballistocardiographic Sensor in Patients with Sleep Disordered Breathing. Scientific Reports. 7: 13175. PMID 29030566 DOI: 10.1038/s41598-017-13138-0 |
0.062 |
|
2009 |
Knüchel R, Koufou SV, Speicher M, Schwamborn K, Zaak D, Stöhr R. [Precancerous lesions of the urothelium. From Feulgen staining to single cell CGH]. Der Pathologe. 29: 364-70. PMID 18604536 DOI: 10.1007/s00292-008-1015-1 |
0.062 |
|
2018 |
Stöhr R, Deckers N, Schurgers L, Marx N, Reutelingsperger CP. AnnexinA5-pHrodo: a new molecular probe for measuring efferocytosis. Scientific Reports. 8: 17731. PMID 30532026 DOI: 10.1038/s41598-018-35995-z |
0.062 |
|
2014 |
Menghini R, Stöhr R, Federici M. MicroRNAs in vascular aging and atherosclerosis. Ageing Research Reviews. 17: 68-78. PMID 24681293 DOI: 10.1016/j.arr.2014.03.005 |
0.062 |
|
2021 |
Balfanz P, Hartmann B, Müller-Wieland D, Kleines M, Häckl D, Kossack N, Kersten A, Cornelissen C, Müller T, Daher A, Stöhr R, Bickenbach J, Marx G, Marx N, Dreher M. Early risk markers for severe clinical course and fatal outcome in German patients with COVID-19. Plos One. 16: e0246182. PMID 33513168 DOI: 10.1371/journal.pone.0246182 |
0.061 |
|
2012 |
Ovsiannikov D, Stöhr R, Hartmann A, Böttrich R, Hengstler JG, Golka K. [Bladder cancer at an early age in father and son]. Der Urologe. Ausg. A. 50: 1614-6. PMID 21938565 DOI: 10.1007/s00120-011-2704-6 |
0.06 |
|
2016 |
Füssel S, Kramer MW, Stöhr R, Olbert P, Nawroth R, Schulz WA. [Report on the 5th symposium of the German research network bladder carcinoma]. Der Urologe. Ausg. A. PMID 27138635 DOI: 10.1007/s00120-016-0100-y |
0.06 |
|
2021 |
Morioka N, Babin C, Nagy R, Gediz I, Hesselmeier E, Liu D, Joliffe M, Niethammer M, Dasari D, Vorobyov V, Kolesov R, Stöhr R, Ul-Hassan J, Son NT, Ohshima T, et al. Author Correction: Spin-controlled generation of indistinguishable and distinguishable photons from silicon vacancy centres in silicon carbide. Nature Communications. 12: 5978. PMID 34620847 DOI: 10.1038/s41467-021-25869-w |
0.06 |
|
2014 |
Stöhr CG, Stöhr R, Rogler A, Amann K, Knüchel-Clarke R, Hartmann A. [Personalized urooncology based on molecular uropathology: part 1: what is diagnostic routine?]. Der Urologe. Ausg. A. 52: 970-5. PMID 23801163 DOI: 10.1007/s00120-013-3228-z |
0.059 |
|
2014 |
Stöhr R, Marx N, Federici M. Tick-tock: Is your cardiometabolic risk on the clock? Diabetes and Vascular Disease Research. 11: 66-74. PMID 24396116 DOI: 10.1177/1479164113516348 |
0.058 |
|
2021 |
Rapp N, Brandenburg VM, Kaesler N, Bakker SJL, Stöhr R, Schuh A, Evenepoel P, Schurgers LJ. Hepatic and Vascular Vitamin K Status in Patients with High Cardiovascular Risk. Nutrients. 13. PMID 34684491 DOI: 10.3390/nu13103490 |
0.057 |
|
2015 |
Lehrke M, Kahles F, Makowska A, Tilstam PV, Diebold S, Marx J, Stöhr R, Hess K, Endorf EB, Bruemmer D, Marx N, Findeisen HM. PDE4 inhibition reduces neointima formation and inhibits VCAM-1 expression and histone methylation in an Epac-dependent manner. Journal of Molecular and Cellular Cardiology. 81: 23-33. PMID 25640159 DOI: 10.1016/j.yjmcc.2015.01.015 |
0.057 |
|
2022 |
Philipp T, Huittinen N, Shams Aldin Azzam S, Stohr R, Stietz J, Reich T, Schmeide K. Effect of Ca(II) on U(VI) and Np(VI) retention on Ca-bentonite and clay minerals at hyperalkaline conditions - New insights from batch sorption experiments and luminescence spectroscopy. The Science of the Total Environment. 842: 156837. PMID 35750178 DOI: 10.1016/j.scitotenv.2022.156837 |
0.053 |
|
2015 |
Stöhr R, Kappel BA, Carnevale D, Cavalera M, Mavilio M, Arisi I, Fardella V, Cifelli G, Casagrande V, Rizza S, Cattaneo A, Mauriello A, Menghini R, Lembo G, Federici M. TIMP3 interplays with apelin to regulate cardiovascular metabolism in hypercholesterolemic mice. Molecular Metabolism. 4: 741-52. PMID 26500845 DOI: 10.1016/J.Molmet.2015.07.007 |
0.052 |
|
2013 |
Stöhr R, Federici M. Insulin resistance and atherosclerosis: convergence between metabolic pathways and inflammatory nodes. The Biochemical Journal. 454: 1-11. PMID 23889252 DOI: 10.1042/BJ20130121 |
0.051 |
|
2022 |
Thiele K, Cornelissen A, Florescu R, Kneizeh K, Brandenburg VM, Witte K, Marx N, Schuh A, Stöhr R. The Role of Vitamin D as an Independent Predicting Marker for One-Year Mortality in Patients with Acute Heart Failure. Journal of Clinical Medicine. 11. PMID 35628860 DOI: 10.3390/jcm11102733 |
0.051 |
|
2023 |
Mause SF, Berger M, Lim HY, Vogt F, Brandenburg V, Stöhr R. Intravenous iron supplementation in heart failure patients induces temporary endothelial dysfunction with release of endothelial microvesicles. Frontiers in Immunology. 13: 1092704. PMID 36761158 DOI: 10.3389/fimmu.2022.1092704 |
0.047 |
|
2017 |
Erber R, Stöhr R, Herlein S, Giedl C, Rieker RJ, Fuchs F, Ficker JH, Hartmann A, Veltrup E, Wirtz RM, Brueckl WM. Comparison of PD-L1 mRNA Expression Measured with the CheckPoint Typer® Assay with PD-L1 Protein Expression Assessed with Immunohistochemistry in Non-small Cell Lung Cancer. Anticancer Research. 37: 6771-6778. PMID 29187455 DOI: 10.21873/anticanres.12137 |
0.046 |
|
2017 |
Stöhr R, Schurgers L, van Gorp R, Jaminon A, Marx N, Reutelingsperger C. Annexin A5 reduces early plaque formation in ApoE -/- mice. Plos One. 12: e0190229. PMID 29267398 DOI: 10.1371/journal.pone.0190229 |
0.046 |
|
2002 |
Stohr R, Waberski A, Völker H, Tindall BJ, Thomm M. Hydrogenothermus marinus gen. nov., sp. nov., a novel thermophilic hydrogen-oxidizing bacterium, recognition of Calderobacterium hydrogenophilum as a member of the genus Hydrogenobacter and proposal of the reclassification of Hydrogenobacter acidophilus as Hydrogenobaculum acidophilum gen. nov., comb. nov., in the phylum 'Hydrogenobacter/Aquifex'. International Journal of Systematic and Evolutionary Microbiology. 51: 1853-1862. PMID 11594618 DOI: 10.1099/00207713-51-5-1853 |
0.045 |
|
2015 |
Stöhr R, Mavilio M, Marino A, Casagrande V, Kappel B, Möllmann J, Menghini R, Melino G, Federici M. ITCH modulates SIRT6 and SREBP2 to influence lipid metabolism and atherosclerosis in ApoE null mice. Scientific Reports. 5: 9023. PMID 25777360 DOI: 10.1038/srep09023 |
0.045 |
|
2007 |
Bringmann G, Gulder TA, Lang G, Schmitt S, Stöhr R, Wiese J, Nagel K, Imhoff JF. Large-scale biotechnological production of the antileukemic marine natural product sorbicillactone A. Marine Drugs. 5: 23-30. PMID 18463724 DOI: 10.3390/Md502023 |
0.044 |
|
2016 |
Mavilio M, Marchetti V, Fabrizi M, Stöhr R, Marino A, Casagrande V, Fiorentino L, Cardellini M, Kappel B, Monteleone I, Garret C, Mauriello A, Monteleone G, Farcomeni A, Burcelin R, et al. A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction. Cell Reports. 16: 2269. PMID 27558826 DOI: 10.1016/j.celrep.2016.07.078 |
0.043 |
|
2016 |
Kahles F, Meyer C, Diebold S, Foldenauer AC, Stöhr R, Möllmann J, Lebherz C, Findeisen HM, Marx N, Lehrke M. GIP secretion is induced by inflammatory stimuli in an IL-1-dependent manner in mice. Diabetes, Obesity & Metabolism. PMID 27350651 DOI: 10.1111/dom.12711 |
0.041 |
|
2019 |
Stöhr R, Sandstede L, Heine GH, Marx N, Brandenburg V. High-Dose Ferric Carboxymaltose in Patients With HFrEF Induces Significant Hypophosphatemia. Journal of the American College of Cardiology. 71: 2270-2271. PMID 29747838 DOI: 10.1016/j.jacc.2018.03.448 |
0.037 |
|
2003 |
GIBITZ H, STOHR R, ZIERHUT H. [Metabolic studies in liver diseases in children; contribution to the infantile liver cirrhosis in Tirol]. Munchener Medizinische Wochenschrift (1950). 95: 1293-5. PMID 13132867 |
0.035 |
|
2001 |
Stöhr R, Waberski A, Liesack W, Völker H, Wehmeyer U, Thomm M. Hydrogenophilus hirschii sp. nov., a novel thermophilic hydrogen-oxidizing beta-proteobacterium isolated from Yellowstone National Park. International Journal of Systematic and Evolutionary Microbiology. 51: 481-488. PMID 11321094 DOI: 10.1099/00207713-51-2-481 |
0.035 |
|
2016 |
Kappel BA, Stöhr R, De Angelis L, Mavilio M, Menghini R, Federici M. Posttranslational modulation of FoxO1 contributes to cardiac remodeling in post-ischemic heart failure. Atherosclerosis. 249: 148-56. PMID 27105158 DOI: 10.1016/j.atherosclerosis.2016.04.001 |
0.03 |
|
2008 |
Keck B, Stöhr R, Goebell PJ, Fritsche HM, Wullich B, Hartmann A. Plasmacytoid carcinoma: Five case reports of a rare variant of urothelial carcinoma | Das plasmazytoide urothelkarzinom: 5 Fallberichte einer seltenen variante des konventionellen urothelkarzinoms Pathologe. 29: 379-382. PMID 18600326 DOI: 10.1007/s00292-008-1017-z |
0.029 |
|
2020 |
Dreher M, Kersten A, Bickenbach J, Balfanz P, Hartmann B, Cornelissen C, Daher A, Stöhr R, Kleines M, Lemmen SW, Brokmann JC, Müller T, Müller-Wieland D, Marx G, Marx N. The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS. Deutsches Arzteblatt International. 117: 271-278. PMID 32519944 DOI: 10.3238/arztebl.2020.0271 |
0.028 |
|
2018 |
Stöhr R, Schuh A, Heine GH, Brandenburg V. Corrigendum: FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator? Frontiers in Endocrinology. 9: 422. PMID 30061865 DOI: 10.3389/fendo.2018.00422 |
0.021 |
|
2012 |
Stöhr R, Dohmen G, Herpertz R, Brehmer K, Aktug O, Koos R, Altiok E, Stegemann E, Autschbach R, Marx N, Hoffmann R. Thirty-day outcome after transcatheter aortic valve implantation compared with surgical valve replacement in patients with high-risk aortic stenosis: a matched comparison. Coronary Artery Disease. 22: 595-600. PMID 22009042 DOI: 10.1097/MCA.0b013e32834d335e |
0.018 |
|
2022 |
Gersmann AK, Haller F, Behnert N, Richter A, Stöhr R, Hartmann A, Ströbel P, Bremmer F. Primary pseudomyogenic haemangioendothelioma of the testis with a novel POTEI::FOSB gene fusion. Histopathology. 81: 411-414. PMID 35582841 DOI: 10.1111/his.14697 |
0.016 |
|
2008 |
STOHR R. [On the question of glyconeogeny in the organism]. Wiener Klinische Wochenschrift. 60: 540. PMID 18934381 |
0.014 |
|
2008 |
STOHR R. [On the question of glyconeogeny in the organism]. Wiener Klinische Wochenschrift. 60: 661-6. PMID 18102369 |
0.014 |
|
2020 |
Brandenburg V, Heine GH, Marx N, Stöhr R. Sharp rises in FGF23 and hypophosphatemia after intravenous iron administration do not cause myocardial damage. Clinical Research in Cardiology : Official Journal of the German Cardiac Society. 109: 1316-1318. PMID 32215701 DOI: 10.1007/s00392-020-01630-z |
0.013 |
|
2008 |
STOHR R. Colorimetric determination of picric acid in picrates. The Biochemical Journal. 44: xxxv. PMID 18229372 |
0.011 |
|
2018 |
Korn K, Coras R, Bobinger T, Herzog SM, Lücking H, Stöhr R, Huttner HB, Hartmann A, Ensser A. Fatal Encephalitis Associated with Borna Disease Virus 1. The New England Journal of Medicine. 379: 1375-1377. PMID 30281979 DOI: 10.1056/NEJMc1800724 |
0.01 |
|
2014 |
Stöhr R, Cavalera M, Menini S, Mavilio M, Casagrande V, Rossi C, Urbani A, Cardellini M, Pugliese G, Menghini R, Federici M. Loss of TIMP3 exacerbates atherosclerosis in ApoE null mice. Atherosclerosis. 235: 438-43. PMID 24943223 DOI: 10.1016/j.atherosclerosis.2014.05.946 |
0.01 |
|
2004 |
HOLZER FJ, STOHR R. [Mass poisoning of sheep by sodium chlorate herbicide]. Schweizer Archiv Fur Tierheilkunde. 92: 339-54. PMID 15442044 |
0.01 |
|
2003 |
OBERRAUCH H, STOHR R. [A few compounds of sulfanilic acid and amino acids]. Hoppe-Seyler's Zeitschrift Fur Physiologische Chemie. 290: 70-1. PMID 12989935 |
0.01 |
|
Hide low-probability matches. |